Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications.

McDonald, L. C.; Kuehnert, M. J.; Tenover, F. C.; Jarvis, W. R.

Back to Previous Page

Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications.

Published Date:

1997 Jul-Sep

Source:

Emerg Infect Dis. 3(3):311-317.

Language:

English

[PDF-46.95 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

McDonald, L. C. ; Kuehnert, M. J. ; Tenover, F. C. ; Jarvis, W. R. ;

Description:

Although nosocomial acquisition and subsequent colonization of vancomycin-resistant enterococci (VRE), an emerging international threat to public health, has been emphasized in the United States, colonization among nonhospitalized persons has been infrequently documented. In contrast, in Europe, colonization appears to occur frequently in persons outside the health-care setting. An important factor associated with VRE in the community in Europe has been avoparcin, a glycopeptide antimicrobial drug used for years in many European nations at subtherapeutic doses as a growth promoter in food-producing animals. In Europe, evidence suggests that foodborne VRE may cause human colonization. Although avoparcin has never been approved for use in the United States, undetected community VRE transmission may be occurring at low levels. Further studies of community transmission of VRE in the United States are urgently needed. If transmission with VRE from unrecognized community sources can be identified and controlled, increased incidence of colonization and infection among hospitalized patients may be prevented.

Subject:

[+]

Document Type:

Journal Article

Place as Subject:

United States

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

File Type:

Supporting Files:

	9284375.nxml	text/plain
	license.txt	text/plain

No Related Documents.

Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe.

[PDF - 85.14 KB]

Personal Author:

Wegener, H. C. ; Aarestrup, F. M. ; ...

Published Date:

1999 May-Jun

Source:

Emerg Infect Dis. 5(3):329-335.

Description:

Supplementing animal feed with antimicrobial agents to enhance growth has been common practice for more than 30 years and is estimated to constitute m...

File Type:

[PDF - 85.14 KB]

File Type:

[PDF - 85.14 KB]
Proficiency of clinical laboratories in and near Monterrey, Mexico, to detect vancomycin-resistant enterococci.

[PDF - 52.28 KB]

Personal Author:

McDonald, L. C. ; Garza, L. R. ; ...

Published Date:

1999 Jan-Feb

Source:

Emerg Infect Dis. 5(1):143-146.

Description:

Early detection of vancomycin-resistant enterococci is important for preventing its spread among hospitalized patients. We surveyed the ability of eig...

File Type:

[PDF - 52.28 KB]

File Type:

[PDF - 52.28 KB]
Recommendations for preventing the spread of vancomycin resistance; recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC)

[PDF - 212.01 KB]

Personal Author:

Favero, Martin S. ; Gaynes, Robert P. ; ...

Corporate Authors:

Hospital Infection Control Practices Advisory Committee (U.S.) ; Centers for Disease Control and Prevention (CDC) ; ...

Published Date:

September 22, 1995

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 44, no. RR-12
HHS Publication ; no. (CDC) 95-8017

Description:

Since 1989, a rapid increase in the incidence of infection and colonization with vancomycin-resistant enterococci (VRE) has been reported by U.S. hosp...

Status:

retired

File Type:

[PDF - 212.01 KB]

File Type:

[PDF - 212.01 KB]
Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future.

[PDF - 195.70 KB]

Personal Author:

Huycke, M. M. ; Sahm, D. F. ; ...

Published Date:

1998 Apr-Jun

Source:

Emerg Infect Dis. 4(2):239-249.

Description:

Enterococci, leading causes of nosocomial bacteremia, surgical wound infection, and urinary tract infection, are becoming resistant to many and someti...

File Type:

[PDF - 195.70 KB]

File Type:

[PDF - 195.70 KB]
Emergence of vancomycin-resistant enterococci.

[PDF - 61.72 KB]

Personal Author:

Rice, L. B.

Published Date:

2001 Mar-Apr

Source:

Emerg Infect Dis. 7(2):183-187.

Description:

Vancomycin and ampicillin resistance in clinical Enterococcus faecium strains has developed in the past decade. Failure to adhere to strict infection ...

File Type:

[PDF - 61.72 KB]

File Type:

[PDF - 61.72 KB]

Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications.

Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications.

You May Also Like:

Have Questions?

CDC INFORMATION

CONNECT WITH CDC